RKLB Rocket Lab Corp

NEUTRAL Impact: 3/10 144
Horizon immediate Filed May 27, 2026 Processed 10d 23h ago SEC 0002001011-26-000067
Form 144 — notice of proposed sale of securities

Price Chart

Loading chart...

Executive Summary

Arjun Kampani, CFO of Rocket Lab, filed a Form 144 to sell up to 28,668 shares (valued at ~$4.09M based on the filing date). The shares were acquired via restricted stock vesting on 05/22/2026, and the sale is partly to cover tax obligations from vested equity. While CFO sales often draw scrutiny, this appears routine—a planned sale tied to equity vesting and tax withholding, not a discretionary market exit. At a $78.6B market cap, the ~$4.09M sale represents ~0.005% of shares outstanding, immaterial from a fundamental perspective.

Actionable Insight

No actionable signal for traders. This is a routine 144 filed by the CFO in conjunction with restricted stock vesting and tax withholding—not a discretionary liquidation. The dollar amount ($4.09M) is negligible relative to the $78.6B market cap. Monitor for any non-tax-motivated insider sales in the coming weeks that could signal a change in sentiment.

Key Facts

  • Reporting owner: Arjun Kampani, CFO (Officer designation on Form 144)
  • Proposed sale: 28,668 shares of common stock
  • Aggregate market value: ~$4,087,297 (21,135 shares at $1,429.66 avg + 7,533 shares at $1,425.60 avg, per broker estimate on filing date 05/26/2026)
  • Shares acquired via restricted stock vesting on 05/22/2026 (compensation; 38,685 + 13,787 shares)
  • Sale includes shares to cover tax obligations from vested equity award distribution
  • Broker: Morgan Stanley Smith Barney LLC Executive Services
  • Market cap: ~$78.6B; proposed sale represents ~0.005% of total shares outstanding
  • Prior 3 months: Kafka sold 28,761 shares total ($2.0M) in two transactions (03/02/2026 and 03/04/2026)

Financial Impact

Proposed sale of $4.09M in common stock at a $78.6B market cap (0.005% of shares); primarily to cover tax withholding on vested RSUs

dilutioninsider holdings

Risk Factors

  • If RKLB stock price appreciates sharply, additional tax-related sales could occur, creating transient selling pressure
  • Biotech/space names with high volatility can see insider sales misread by retail as bearish

Market Snapshot

Exchange
Nasdaq
Sector
Guided Missiles & Space Vehicles & Parts
Analyst Consensus
78% bullish (27 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0002001011-26-000067
Document: 0002001011-26-000067-index.html0002001011-26-000067
Document: 0002001011-26-000067.txt0002001011-26-000067
21 reports for RKLB
Performance horizon
88% Hit rate 7 of 8 directional calls best @ T+20▲ +59.73%Apr 14, 2026
Filters
Rows
Reports for RKLB — sortable, filterable
Type Now
Jun 5, 2026
1d ago
Insider Cluster
NEUTRAL ★ 3/10
$109.00 awaiting T+1awaiting T+1$110.08 (+0.99%)
Jun 5, 2026
1d ago
3
NEUTRAL ★ 2/10
$109.50 awaiting T+1awaiting T+1$110.08 (+0.53%)
Jun 1, 2026
5d ago
Insider Cluster
BEARISH ★ 5/10
$123.32 $114.70▲ +6.99%▲ +6.27%$110.08 (+10.74%)
Jun 1, 2026
5d ago
Insider Cluster
NEUTRAL ★ 3/10
$123.32 $114.70▼ −6.99%▼ −6.30%$110.08 (−10.74%)
Jun 1, 2026
5d ago
Insider Cluster
NEUTRAL ★ 2/10
$123.32 $114.70▼ −6.99%▼ −6.30%$110.08 (−10.74%)
May 29, 2026
9d ago
Insider Cluster
BEARISH ★ 5/10
awaiting T+1
May 27, 2026
10d ago
144
NEUTRAL ★ 4/10
$148.03 $143.48▼ −3.07%▼ −3.32%$110.08 (−25.64%)
May 27, 2026
10d ago
144
NEUTRAL ★ 3/10
$150.23 $148.03▼ −1.46%▼ −2.02%$110.08 (−26.73%)
May 27, 2026
10d ago
144
NEUTRAL ★ 3/10
awaiting T+1
May 27, 2026
10d ago
144
NEUTRAL ★ 3/10
awaiting T+1
Showing 10 of 21

US Market Status

Market Closed — Opens Mon (12h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access